SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-18-005261
Filing Date
2018-08-10
Accepted
2018-08-10 16:58:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7966736_13da.htm SC 13D/A 88514
  Complete submission text file 0000919574-18-005261.txt   90018
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88748 | Film No.: 181009474
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A